A Multicomponent Physical Activity Intervention for Older Adults (ActiveKIT)

July 22, 2026 updated by: David Martinez Gomez, Universidad Autonoma de Madrid

A Multicomponent Physical Activity Intervention for Older Adults: the ActiveKIT Randomized Controlled Trial

ActiveKIT is a three-arm, parallel-group, individually randomized controlled trial. Community-dwelling adults aged 65 years or older (n=201) from Madrid and surrounding municipalities who were inactive were randomized into tree arms: a low-cost home-based exercise toolkit, the same toolkit plus remote specialist support, or usual-care. The intervention lasted 12 weeks, with assessments at baseline, 3 months, and 12 months.

Study Overview

Study Type

Interventional

Enrollment (Actual)

201

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain
        • Universidad Autonoma de Madrid

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participants were eligible if they were aged 65 years or older and able to undertake physical activity safely, with no contraindications to increasing their physical activity level

Exclusion Criteria:

  • Participants were excluded if they met any of the following criteria:

    • Institutionalized or housebound;
    • Three or more falls, or one or more falls requiring medical attention, in the previous year;
    • Terminal illness;
    • Cognitive impairment precluding the ability to follow simple instructions;
    • Blindness;
    • New onset within the previous three months of conditions such as chest pain, myocardial infarction, coronary artery bypass graft, or angioplasty;
    • Chronic or acute conditions that contraindicated increased physical activity, such as pneumonia, acute rheumatoid arthritis, unstable or acute heart failure, significant neurological disease or impairment, inability to move about independently, or severe psychiatric disorders;
    • Already physically active, defined as self-reported attainment of any of the three public health physical activity recommendations for older adults (aerobic activity, muscle-strengthening activity, or balance training), because the intervention was specifically designed for inactive older adults.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual care
Standardized written information consistent with current public health recommendations on multicomponent physical activity to maintain or improve physical function.
Experimental: Exercise toolkit
A low-cost, easy-to-use, home-based exercise toolkit designed to promote multicomponent physical activity and improve physical function.
At the start of the intervention, participants received a home-delivered toolkit and a printed exercise guide. The toolkit included a smartwatch to monitor daily physical activity, color-coded resistance bands, an exercise mat, a gymnastic stick, cones, and a light dumbbell to support aerobic, strength, balance, coordination, flexibility, and mobility training. The guide provided a structured 12-week progressive multicomponent program covering the four physical activity domains recommended for older adults: aerobic exercise, muscle strengthening, balance/coordination, and flexibility. Training volume and difficulty increased weekly, with walking progressing from 15 to 55 minutes per session and strength and balance exercises from 8 to 12 repetitions per set. Standing, seated, and supported exercise options were included to accommodate different functional capacities and promote safe progression toward WHO physical activity recommendations
Experimental: Exercise toolkit plus specialist support
The same exercise toolkit supplemented with remote support from an exercise specialist delivered through virtual channels (for example, video or audio calls, messaging applications, and social networks).
In addition to the exercise toolkit, participants allocated to Arm 2 received remote support from an exercise specialist with training in physical activity promotion and behavior-change techniques. Support focused on goal setting, identification of barriers and facilitators, problem solving, progression of activities, motivation, and safety. Participants selected their preferred communication channel, including telephone calls, video calls, messaging applications, or social media platforms. Each participant received two scheduled 15-minute contacts per week throughout the intervention, with a maximum of two additional contacts available upon request when additional support was needed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in 30-Second Chair Stand Test
Time Frame: Baseline, 3 months and 12 months
Baseline, 3 months and 12 months
Change in hand grip strength
Time Frame: Baseline, 3 months and 12 months
Baseline, 3 months and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in 2-Minute Step Test
Time Frame: Baseline, 3 months and 12 months
Baseline, 3 months and 12 months
Change in Timed Up and Go test
Time Frame: Baseline, 3 months and 12 months
Baseline, 3 months and 12 months
Change in Back Scratch Test
Time Frame: Baseline, 3 months and 12 months
Baseline, 3 months and 12 months
Change in Chair Sit-and-Reach Test
Time Frame: Baseline, 3 months and 12 months
Baseline, 3 months and 12 months
Change in the International Fitness Scale
Time Frame: Baseline, 3 months and 12 months
Perceived overall and fitness components using a five-point Likert response scale ranging from 1 to 5 (very poor, poor, average, good, and very good)
Baseline, 3 months and 12 months
Change in the IMPaCT physical activity and sedentary behavior questionnaire
Time Frame: Baseline, 3 months and 12 months
Intensity, duration, type and context of PA (leisure, transport, occupational, domestic)
Baseline, 3 months and 12 months
Change in wrist-worn accelerometer behaviors
Time Frame: Baseline, 3 months and 12 months
Minutes in moderate-to vigorous physical activity, light-intensity physical activity, and sedentary time
Baseline, 3 months and 12 months
Change in wrist-worn accelerometer activity
Time Frame: Baseline, 3 months and 12 months
Total movement (mg)
Baseline, 3 months and 12 months
Change in wrist-worn step patterns
Time Frame: Baseline, 3 months and 12 months
Daily steps and cadence
Baseline, 3 months and 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in adherence to the Mediterranean diet
Time Frame: Baseline, 3 months and 12 months
14-item Mediterranean Diet Adherence Screener, Score 0-14, higher = better adherence.
Baseline, 3 months and 12 months
Change in sleep duration
Time Frame: Baseline, 3 months and 12 months
Average night and nap duration
Baseline, 3 months and 12 months
Daytime sleepiness
Time Frame: Baseline, 3 months and 12 months
Epworth Sleepiness Scale, Spanish version
Baseline, 3 months and 12 months
Change in Health-related quality of life
Time Frame: Baseline, 3 months and 12 months
EuroQol EQ-5D-3L
Baseline, 3 months and 12 months
Change in depressive symptoms
Time Frame: Baseline, 3 months and 12 months
10-item Geriatric Depression Scale
Baseline, 3 months and 12 months
Change in self-efficacy
Time Frame: Baseline, 3 months and 12 months
Spanish General Self-Efficacy Scale; 10 items, 4-point Likert, higher = greater
Baseline, 3 months and 12 months
Change in physical activity enjoyment
Time Frame: Baseline, 3 months and 12 months
Single-item score ranging from 1 to 10; higher scores indicate greater enjoyment.
Baseline, 3 months and 12 months
Change in body mass index
Time Frame: Baseline, 3 months and 12 months
Derived from height and weight in kg/m2
Baseline, 3 months and 12 months
Change in waist circumference
Time Frame: Baseline, 3 months and 12 months
Baseline, 3 months and 12 months
Change in blood pressure
Time Frame: Baseline, 3 months and 12 months
Baseline, 3 months and 12 months
Change in resting heart rate
Time Frame: Baseline, 3 months and 12 months
Baseline, 3 months and 12 months
Safety during and after the intervention
Time Frame: 3 months and 12 months
Adverse events (frequency) were also systematically assessed at the 3- and 12-month follow-up visits and included falls, injuries, exacerbations of pre-existing conditions, major cardiovascular events, hospitalizations, and deaths.
3 months and 12 months
Economic costs of the intervention
Time Frame: Baseline and 3 months
Baseline and 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 6, 2023

Primary Completion (Actual)

March 14, 2025

Study Completion (Actual)

March 14, 2025

Study Registration Dates

First Submitted

July 20, 2026

First Submitted That Met QC Criteria

July 22, 2026

First Posted (Actual)

July 27, 2026

Study Record Updates

Last Update Posted (Actual)

July 27, 2026

Last Update Submitted That Met QC Criteria

July 22, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PI20/00657

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on Exercise toolkit

Subscribe